share

3H-Imidazo[1,2-A]Pyrrolo[2,3-E]Pyrazine, 8-[(3R,4S)-4-Ethyl-3-Pyrrolidinyl]-, Hydrochloride (1:2) CAS NO 2050038-84-9


Unit Price:

CAS No.:2050038-84-9

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

3H-Imidazo[1,2-A]Pyrrolo[2,3-E]Pyrazine, 8-[(3R,4S)-4-Ethyl-3-Pyrrolidinyl]-, Hydrochloride (1:2) is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is critical for research and development in medicinal chemistry, particularly for its potential role in targeting specific biological pathways. It is primarily utilized by pharmaceutical companies, biotechnology research firms, and academic institutions engaged in the synthesis of novel active pharmaceutical ingredients (APIs).

Application

  • Pharmaceutical Intermediate: Key building block in the synthesis of novel drug candidates, particularly in oncology and central nervous system (CNS) therapeutic areas.
  • Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for new chemical entities.
  • Biochemical Research: Serves as a tool compound for investigating enzyme inhibition and receptor binding activities in vitro.
  • Process Development: Employed in scaling up synthetic routes from laboratory to pilot plant scale under GMP conditions.
  • Reference Standard: Used as a high-purity analytical standard for quality control and method validation in API manufacturing.

Basic Information

Product Name 3H-Imidazo[1,2-A]Pyrrolo[2,3-E]Pyrazine, 8-[(3R,4S)-4-Ethyl-3-Pyrrolidinyl]-, Hydrochloride (1:2)
CAS No. 2050038-84-9
Molecular Formula Contact for details
Molecular Weight Contact for details
Synonyms 8-[(3R,4S)-4-Ethyl-3-pyrrolidinyl]-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine dihydrochloride; (3R,4S)-4-Ethyl-8-(3-pyrrolidinyl)-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine hydrochloride (2:1); CAS 2050038-84-9; Imidazopyrrolopyrazine derivative hydrochloride salt
EINECS Contact for details

Quality Control

Our products undergo rigorous quality testing to ensure compliance with industry standards for pharmaceutical intermediates. We implement strict in-process controls and final release testing, which typically includes identification, assay, and impurity profile analysis. Certificates of Analysis (COA) detailing purity, chiral purity (where applicable), and residual solvent levels are available upon request. Our quality system supports development under ICH guidelines.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This material is hygroscopic (moisture-sensitive) and must be kept under an inert atmosphere or in a desiccated environment after opening to prevent degradation. Keep away from incompatible materials.

Specification

Item Specification
Appearance White to off-white solid
Identification (HPLC/IR) Conforms to reference standard
Assay (HPLC) ≥ 98.0%
Chiral Purity (HPLC) ≥ 99.0%
Water Content (KF) ≤ 1.0%
Residual Solvents (GC) Meets ICH Q3C guidelines
Heavy Metals < 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.